• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Infectious Agents and Stroke: A Systematic Review
CONCLUSION: Considering the adverse role of the above-mentioned microorganisms, it is necessary to implement some preventive measures for stroke treatment.PMID:35154584 | PMC:PMC8817172 | DOI:10.32598/bcn.2021.1324.2
Source: Herpes - February 14, 2022 Category: Infectious Diseases Authors: Alia Saberi Shahin Akhondzadeh Samira Kazemi Samaneh Kazemi Source Type: research

Correspondence Infectious causes of stroke
Although the causality of hepatitis C virus in stroke is not conclusive, some clinical studies have shown an increased risk of stroke in patients with chronic hepatitis C. In their Review, Jennifer Fugate and colleagues1 propose several interesting hypotheses to explain the link between chronic infection and stroke that might also be applied to the association of hepatitis C virus infection with stroke. Accumulating evidence shows the metabolic manifestations of hepatitis C virus, and provides a strong link between hepatitis C virus clearance and a decrease in the risk of stroke.
Source: The Lancet Infectious Diseases - May 18, 2015 Category: Infectious Diseases Authors: Ching-Sheng Hsu Tags: Correspondence Source Type: research

Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV‐positive patients
Summary Patients infected with HIV are at increased risk for cardiovascular disease despite successful antiretroviral therapy. Likewise, chronic hepatitis C virus (HCV) infection is associated with extrahepatic complications, including cardiovascular disease. However the risk of cardiovascular disease has not been formally examined in HIV/HCV‐coinfected patients. A retrospective study was carried out to assess the influence of HCV coinfection on the risk of cardiovascular events in a large cohort of HIV‐infected patients recruited since year 2004. A composite event of cardiovascular disease was used as an endpoint, inc...
Source: Journal of Viral Hepatitis - September 22, 2015 Category: Infectious Diseases Authors: J. V. Fernández‐Montero, P. Barreiro, C. Mendoza, P. Labarga, V. Soriano Tags: Original Article Source Type: research

Antivirals for HCV improve kidney and cardiovascular diseases in diabetic patients
(Wiley) Researchers from Taiwan reveal that antiviral therapy for hepatitis C virus (HCV) improves kidney and cardiovascular outcomes for patients with diabetes. Results of the study published in Hepatology, a journal of the American Association for the Study of Liver Diseases, show that incidences of kidney disease, stroke, and heart attack were lower in patients treated with pegylated interferon and ribavirin compared to HCV patients not treated with antivirals or diabetic patients not infected with the virus.
Source: EurekAlert! - Infectious and Emerging Diseases - December 11, 2013 Category: Infectious Diseases Source Type: news

Performance of the Pooled Cohort Atherosclerotic Cardiovascular Disease Risk Score in Hepatitis C Virus ‐infected Persons
This article is protected by copyright. All rights reserved.
Source: Journal of Viral Hepatitis - March 7, 2017 Category: Infectious Diseases Authors: Kara W. Chew, Debika Bhattacharya, Tamara B. Horwich, Peng Yan, Kathleen A. McGinnis, Chi ‐hong Tseng, Matthew S. Freiberg, Judith S. Currier, Adeel A. Butt Tags: Original Paper Source Type: research

HIV/HCV Co ‐infection and the risk of Cardiovascular Disease: A Meta‐analysis
In conclusion, individuals with HIV/HCV coinfection had an increased risk compared to those with HIV monoinfection. More research is needed to further examine the nature of this association, and response to traditional risk reductive therapies. This article is protected by copyright. All rights reserved.
Source: Journal of Viral Hepatitis - May 1, 2017 Category: Infectious Diseases Authors: Olatokunbo Osibogun, Oluseye Ogunmoroti, Erin D. Michos, Erica S. Spatz, Babatunde Olubajo, Khurram Nasir, Purnima Madhivanan, Wasim Maziak Tags: Original Paper Source Type: research

HIV/HCV coinfection and the risk of cardiovascular disease: A meta ‐analysis
In conclusion, individuals with HIV/HCV coinfection had an increased CVD risk compared to those with HIV monoinfection. More research is needed to further examine the nature of this association, and response to traditional risk‐reduction therapies.
Source: Journal of Viral Hepatitis - June 23, 2017 Category: Infectious Diseases Authors: O. Osibogun, O. Ogunmoroti, E. D. Michos, E. S. Spatz, B. Olubajo, K. Nasir, P. Madhivanan, W. Maziak Tags: ORIGINAL ARTICLE Source Type: research

Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen
Conclusion: Despite continued virologic suppression and neurocognitive improvement in the cohort as a whole, older individuals were more likely to have neurocognitive impairment than younger individuals.
Source: AIDS - June 30, 2017 Category: Infectious Diseases Tags: Clinical Science Source Type: research

Insomnia as an Independent Predictor of Incident Cardiovascular Disease in HIV: Data From the Veterans Aging Cohort Study
Background: Insomnia is associated with increased cardiovascular disease (CVD) risk in the general population and is highly prevalent in people with HIV. The CVD risk conferred by insomnia in the HIV population is unknown. Methods: Using the Veterans Aging Cohort Study Survey Cohort, insomnia symptoms were measured and dummy coded with the item, “Difficulty falling or staying asleep?” (5-point scale from no difficulty to bothers a lot). Incident CVD event ICD-9 codes (acute myocardial infarction, stroke, or coronary artery revascularization) were identified with the Department of Veterans Affairs (VA) and Medicare...
Source: JAIDS Journal of Acquired Immune Deficiency Syndromes - April 9, 2019 Category: Infectious Diseases Tags: Clinical Science Source Type: research